Diametric Capital, LP Recursion Pharmaceuticals, Inc. Transaction History

Diametric Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$7.35 - $10.05 $154,357 - $211,060	21,001 Added 92.23%	43,771 $328,000
Q1 2024 May 15, 2024	SELL	$9.13 - $15.52 $382,218 - $649,729	-41,864 Reduced 64.77%	22,770 $227,000
Q4 2023 Feb 13, 2024	SELL	$5.09 - $10.79 $364,937 - $773,610	-71,697 Reduced 52.59%	64,634 $637,000
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $108,240 - $260,500	16,425 Added 13.7%	136,331 $1.04 Million
Q2 2023 Aug 11, 2023	BUY	$4.56 - $9.94 $546,771 - $1.19 Million	119,906 New	119,906 $895,000
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.26 $179,751 - $330,257	35,665 New	35,665 $290,000

286

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.12B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Diametric Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Diametric Capital, LP with notifications on news.